# ClinicalTrials.gov record NCT01023061

> PeptideScanner retained ClinicalTrials.gov record NCT01023061 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-06-06, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct01023061-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-06-06
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01023061-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01023061-leuprolide-v1.json
- Content SHA-256: `44e20935eafb1a7ff8556693b9da4aaf727003c1dc0c85f3bd9c2ff359abe306`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01023061 ([`ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f`](#source-ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01023061 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-06-06, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f`](#source-ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01023061 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-06-06, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f`](#source-ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f`](#source-ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f))

## Sources

<a id="source-ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f"></a>
- **ClinicalTrials.gov record NCT01023061 · retained source version 2017-06-06:efa8c9e2ef9fee3dc6a7b7682eb3f77b907ac5cb94f33d6e6a14bd4a893d78f3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01023061) (`ctg-observation-nct01023061-2017-06-06-efa8c9e2ef9f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01023061." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01023061-leuprolide-v1.json SHA-256: 44e20935eafb1a7ff8556693b9da4aaf727003c1dc0c85f3bd9c2ff359abe306.